Inactive Instrument

AMAG Pharmaceuticals, Inc.

AMAG

US00163U1060

AMAG Pharmaceuticals, Inc. Announces J. Alan Butcher to Resign as the Executive Vice President and Chief Business Officer, Effective December 20, 2019

December 03, 2019 at 04:14 pm

AMAG Pharmaceuticals, Inc. announced that on November 29, 2019, J. Alan Butcher notified the company of his intention to resign as the Executive Vice President and Chief Business Officer of the Company, effective December 20, 2019.

Latest news about AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals, Inc. Files Submission in Response to the Food and Drug Administration’s Notice of Opportunity for A Hearing and Proposal to Withdraw Approval of Makena® (Hydroxyprogesterone Caproate Injection)	20-12-14	CI
AMAG Pharmaceuticals, Inc. Announces Management Changes	20-11-17	CI
AMAG Pharmaceuticals, Inc. Appoints Michael Porter as Chief Executive Officer	20-11-17	CI
AMAG Pharmaceuticals, Inc. Appoints Ozgur Kilic as Chief Financial Officer	20-11-17	CI
AMAG Pharmaceuticals, Inc.(NasdaqGS:AMAG) dropped from S&P 1000	20-11-13	CI
AMAG Pharmaceuticals, Inc.(NasdaqGS:AMAG) dropped from S&P Composite 1500	20-11-13	CI
AMAG Pharmaceuticals, Inc.(NasdaqGS:AMAG) dropped from S&P Global BMI Index	20-11-13	CI
AMAG Pharmaceuticals, Inc.(NasdaqGS:AMAG) dropped from S&P 600 Health Care	20-11-13	CI
AMAG Pharmaceuticals, Inc.(NasdaqGS:AMAG) dropped from S&P 600	20-11-13	CI
AMAG Pharmaceuticals, Inc.(NasdaqGS:AMAG) dropped from S&P TMI Index	20-11-13	CI
AMAG Pharmaceuticals, Inc.(NasdaqGM:AVM) dropped from Russell 2500 Index	20-11-13	CI
AMAG Pharmaceuticals, Inc.(NasdaqGM:AVM) dropped from Russell 2000 Value Index	20-11-13	CI
AMAG Pharmaceuticals, Inc.(NasdaqGM:AVM) dropped from Russell 2500 Value Index	20-11-13	CI
AMAG Pharmaceuticals, Inc.(NasdaqGM:AVM) dropped from Russell Small Cap Completeness Index	20-11-13	CI
AMAG Pharmaceuticals, Inc.(NasdaqGM:AVM) dropped from Russell 3000 Value Index	20-11-13	CI
AMAG Pharmaceuticals, Inc.(NasdaqGM:AVM) dropped from Russell 2000 Index	20-11-13	CI
AMAG Pharmaceuticals, Inc.(NasdaqGM:AVM) dropped from Russell 3000 Index	20-11-13	CI
AMAG Pharmaceuticals, Inc.(NasdaqGM:AVM) dropped from Russell Small Cap Comp Value Index	20-11-13	CI
AMAG Pharmaceuticals, Inc.(NasdaqGM:AVM) dropped from Russell 2000 Value-Dynamic Index	20-11-13	CI
AMAG Pharmaceuticals, Inc.(NasdaqGM:AVM) dropped from Russell 2500 Value-Dynamic Index	20-11-13	CI
AMAG Pharmaceuticals, Inc.(NasdaqGM:AVM) dropped from Russell 2500 Dynamic Index	20-11-13	CI
AMAG Pharmaceuticals, Inc.(NasdaqGM:AVM) dropped from Russell 3000E Index	20-11-13	CI
AMAG Pharmaceuticals, Inc.(NasdaqGM:AVM) dropped from Russell 3000E Value Index	20-11-13	CI
AMAG Pharmaceuticals, Inc.(NasdaqGM:AVM) dropped from Russell Microcap Index	20-11-13	CI
AMAG Pharmaceuticals, Inc.(NasdaqGM:AVM) dropped from Russell Microcap Value Index	20-11-13	CI

Chart AMAG Pharmaceuticals, Inc.

Duration

Period

More charts

Company Profile

AMAG Pharmaceuticals, Inc. is a pharmaceutical company. The Company's segment is the manufacture, development and commercialization of products and services for use in treating various conditions, with a focus on maternal health, anemia management and cancer supportive care. Its offerings focus on maternal health, anemia management and cancer supportive care, including its product, Makena (hydroxyprogesterone caproate injection); its product, Feraheme (ferumoxytol), for intravenous (IV) use, and MuGard Mucoadhesive Oral Wound Rinse. It is engaged in the development of Digoxin immune fab, a polyclonal antibody for the treatment of severe preeclampsia in pregnant women. Makena is a drug indicated to reduce the risk of preterm birth in women pregnant with a single baby having a history of singleton spontaneous preterm birth.

Sector

Pharmaceuticals

More about the company

Sector Other Pharmaceuticals

	1st Jan change	Capi.
ELI LILLY AND COMPANY	+37.74%	723B
NOVO NORDISK A/S	+32.22%	598B
JOHNSON & JOHNSON	-2.07%	364B
MERCK & CO., INC.	+20.25%	331B
ABBVIE INC.	+2.99%	288B
ASTRAZENECA PLC	+16.60%	244B
NOVARTIS AG	+9.77%	210B
ROCHE HOLDING AG	-5.15%	208B
AMGEN INC.	+7.43%	169B

Other Pharmaceuticals